HOUSTON, Sept. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that it will participate in the 2007 UBS Global Life Sciences Conference, being held at the Grand Hyatt Hotel in New York. George Cole, Encysive's President and Chief Executive Officer, will present on Monday, September 24, 2007 at 10:00 a.m. ET.
A live webcast of the presentation may be viewed on the Company's web site at www.encysive.com, and a replay will be available until October 24, 2007.
About Encysive Pharmaceuticals
Encysive Pharmaceuticals Inc. is a global biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. Our research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the vascular endothelium and exploit our expertise in the area of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. To learn more about Encysive Pharmaceuticals please visit our web site: www.encysive.com.
The Encysive Pharmaceuticals Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=843